Search
Close this search box.

WHEN: 12-15 March 2024

WHERE: Newcastle, NSW

TROG Cancer Research Awards for Excellence: Call for nominations OPEN

Nominations are now open for the TROG Cancer Research Excellence Awards. For 2024 there is a standard nomination form for all awards. Award categories include: Lifetime Member, Outstanding Contribution, Trial Excellence, Emerging Clinical Researcher and Peer Recognition.  The nomination form contains details on the nomination process including the award category eligibility and criteria.

Award recipients will be announced at the TROG 2024 ASM Gala Dinner on the evening of Thursday 14th March 2024.

Applications for the 2024 awards close at 5pm Monday 5th March 2024.

Download the Nomination Form and email to trog@trog.com.au

Trans-Tasman Radiation Oncology Group, Home, TROG Cancer Research
Trans-Tasman Radiation Oncology Group, Home, TROG Cancer Research

Trans-Tasman Radiation Oncology Group is one of the largest cancer clinical trials groups in Australia and New Zealand.

Over three decades, the Trans-Tasman Radiation Oncology Group (TROG) has facilitated more than 100 clinical trials that have helped improve the quality of life and treatment options for almost 15,000 volunteer cancer patients. 

During that time, the prognosis of cancer patients has improved considerably. In the 1980s the cancer survival rate was less than 50 per cent. Today, for some cancers, the survival rate is as high as 90 per cent.

TROG Cancer Research is focused on radiation treatment, for the many types of cancers it can treat.

Our upcoming, current, and past clinical trials have investigated the effectiveness of radiation therapy in treating the following groups of cancers. Our members have also investigated the impact of radiation therapy on symptom management and palliative care.

Bladder, Kidney & Prostate Cancers

View the successful TROG trial results and outcomes of all bladder, kidney and prostate cancers trials here.

Bone Cancer

Discover our research within bone cancers and the treatments and trials our team have been apart of.

Brain & Central Nervous System Cancers

Interested in learning more about how TROG contributes to brain and central nervous system cancer results?

Breast Cancer

See how we contribute to a greater understanding of effective treatments for breast cancer patients.

Gastrointestinal Cancer

Understand how TROG contributes to gastrointestinal cancer research and their global results here.

Gynaecological Cancer

View the successful TROG trial results and outcomes of all gynaecological cancer trials here.

Head & Neck Cancer

Eager to more about how TROG contributes to head and neck cancer treatments? Click here.

Lung Cancer

Discover our research within lung cancer and the treatments and trials our team have been apart of.

Lymphoma Cancer

See how we contribute to a broader understanding of effective treatments for lymphoma cancer patients.

Oesophageal Cancer

Explore our current oesophageal cancer trials and the impact of TROG.

Pancreatic Cancer

View the successful TROG trial results and outcomes of all pancreatic cancer trials here.

Skin Cancer

Understand the degree in which TROG contributes to skin cancer research and global results here.

Trans-Tasman Radiation Oncology Group, Home, TROG Cancer Research

Climb for a cause and join our Trek4TROG

This year we will summit Mt Kosciuszko, all in the name of providing better radiation medicine treatments to cancer patients around the world. Our goal is to raise $25,000 and we want you to help us!

Patients who choose to be part of a cancer clinical trial can be assured that patient safety and radiation therapy protocol compliance is stringently monitored under the TROG Cancer Research Radiation Therapy Quality Assurance (RTQA) program.

As new technologies and techniques are incorporated into radiation therapy treatment, RTQA develops robust radiation therapy planning, delivery, and quality assurance guidelines that ensure compliance and trial quality.

We invite you to explore the cancer clinical trials projects and people leading the fight to cure all cancers with one treatment.

Trans-Tasman Radiation Oncology Group, Home, TROG Cancer Research

Not yet a TROG Cancer Research member? Join now

Full membership to the Trans-Tasman Radiation Oncology Group (TROG) is open to anyone qualified in their discipline. This includes Radiation Oncologists, Medical Oncologists, Radiation Therapists, Medical Physicists, Statisticians, Data Managers, Nurses, and Surgeons. 

Affiliate membership is also available to anyone qualified or training in a radiation therapy-related discipline. For full details, visit our membership page.

Industry Blog & News